Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03844646 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03844646: Clinical Trial NA study, sponsored by Stanford University.
NCT03844646 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03844646, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Interventions
- DEVICE CGM
- OTHER Dietitian
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03844646
The ClinicalTrials.gov registry entry for NCT03844646 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CGM is the first listed.
NCT03844646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03844646 about?
NCT03844646 is a clinical study titled "Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes". The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
What is the current status of trial NCT03844646?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-08-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03844646?
The interventions under investigation include: CGM (DEVICE), Dietitian (OTHER).
Who is sponsoring clinical trial NCT03844646?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.